Jingjing Ye
About Jingjing Ye
Jingjing Ye is the Executive Director and Global Head of Data Science and Operational Excellence at BeiGene, with extensive experience in statistical support for cancer drug development and regulatory submissions.
Current Position at BeiGene
Jingjing Ye currently serves as the Executive Director and Global Head of Data Science and Operational Excellence (DSOE) at BeiGene, operating in the Washington DC-Baltimore Area. In this senior leadership role, she oversees data science initiatives to support the development of oncology and hematology drugs. Her responsibilities include strategizing data operations and ensuring excellence across various project pipelines.
Previous Roles at BeiGene
Prior to her current position, Jingjing Ye held the title of Senior Director, Head of Data Science and Operational Excellence, Global Statistics and Data Science at BeiGene from 2020 to 2022. During her tenure, she played a critical role in advancing data initiatives and supporting drug development through precise statistical analyses and operational efficiencies.
Experience at the FDA
Jingjing Ye's career includes several significant roles at the U.S. Food and Drug Administration (FDA). From 2018 to 2020, she worked as Team Leader and Lead Mathematical Statistician in the Center for Drug Evaluation and Research (CDER). Earlier, from 2016 to 2018, she was a Mathematical Statistician in CDER, and from 2010 to 2016, she served as a Mathematical Statistician in the Center for Devices and Radiological Health (CDRH). Her work at the FDA provided her with extensive regulatory knowledge and experience in statistical support for drug and device development.
Educational Background
Jingjing Ye earned her Ph.D. and Master of Science degrees from the University of California, Davis. She completed her Ph.D. from 2003 to 2007 and her M.S. from 2002 to 2003. Before that, she attained her Bachelor of Science degree from Peking University, studying from 1998 to 2002. Her academic background laid a strong foundation for her expertise in statistics and data science.
Professional Expertise
Jingjing Ye specializes in several critical areas within the pharmaceutical and biostatistics fields. Her expertise spans regulatory submissions, clinical trials, oncology and hematology drug development, translational research, biomarker studies in preclinical and clinical trials, and bioinformatics. She has in-depth knowledge of adaptive and Bayesian study designs and provides statistical support and solutions for the development of cancer drugs.